Optimization of drug discovery processes to increase and globalize sales

This project includes both software development and seeking strategic partners to pilot the company’s own drug development projects. In the software development the critical additions to the current in-house method are modifications that enable virtual screening of giga-class databases thus speeding up screening and processing of hit molecules. After the project, Aurlide will have the most efficient and accurate virtual screening method in the world that can accelerate the drug development process considerably. To boost company’s own drug development projects the goal is to identify partners who will strategically support our operations and start a collaboration on common drug development goals and pilot project studies. The pilot projects utilize the expertise of strategic partners in biological measurements, Aurlide’s in-house technology. In total, the project expands the company’s operations and accelerates innovations in the field of medicine.

Co-funded by the European Union

Here’s one crucial thing to understand about molecular docking: Docking scores alone tell you nothing! Take...

Lue lisää

Aurlide proudly presents: PhD (Pharm) Tero Linnanen has joined our team as a Scientific Advisor! Tero...

Lue lisää

We are thrilled to announce that Dr. Elmeri Jokinen is stepping up as the new CEO...

Lue lisää